University of Michigan - C.S. Mott Children's Hospital

Ann Arbor, MI

Description

Behind the doors of C.S. Mott Children’s Hospital there exist teams of people who change children’s lives in extraordinary ways.

This is where the Leaders and Best come together with advanced technologies and breakthrough treatments that change lives.

Since 1903, the University of Michigan has led the way in providing comprehensive, specialized health care for children. Our mission is to integrate clinical care, education, research and advocacy to advance the health status of children, women, and their families and communities statewide.

Families from all over come to the U-M C.S. Mott Children's Hospital for our pediatric expertise.

Housing Information

Contact information

 

1500 E Medical Center Dr, Ann Arbor, MI 48109

Team

Principal Investigator

Andrea Franson, MD MS

Pediatric Oncologist
Dr. Andrea (Flynn) Franson is a Pediatric Oncologist in the Department of Pediatrics at the University of Michigan. She received her bachelor's degree from Rensselaer Polytechnic Institute in Troy, New York and her medical degree from the University of Michigan Medical School. She completed her residency in Pediatrics and fellowship in Pediatric Hematology/Oncology at the Children's Hospital of Philadelphia (CHOP). During fellowship, she earned a master's degree in Pharmacology from Thomas Jefferson University in Philadelphia. While at CHOP, she was an Alex's Lemonade Stand Foundation Center of Excellence Scholar, through which she had mentored training in clinical trial design and pharmacology. Dr. Franson has focused her research efforts in transnational science, working to transition the most promising compounds into the clinic for children with cancer. 
Co-Principal Investigator

Carl Koschmann, MD

Pediatric Neuro-Oncologist
Dr. Koschmann is a Pediatric Neuro-Oncologist in the Department of Pediatrics and a Principal Investigator of an independent translational Pediatric Neuro-Oncology laboratory. His work in the clinic and lab complement and drive each other, resulting in a clear goal to improve therapies for children with brain tumors. He has engaged in research and the clinical care of pediatric brain tumor patients at both Seattle Children’s Hospital and the University of Michigan’s Mott Children’s Hospital. The Koschmann laboratory is exploring the molecular mechanisms by which recurrent mutations in pediatric high-grade glioma (HGG), including glioblastoma (GBM), anaplastic astrocytoma (AA) and diffuse intrinsic pontine glioma (DIPG) promotes tumor formation and affect treatment response.

Andrea Franson, MD MS

Pediatric Oncologist

Carl Koschmann, MD

Pediatric Neuro-Oncologist